In the immunocompromised, however, HPV can reactivate. A Pap smear is typically used to detect cellular changes that occur in the cervix that may indicate a risk of developing cancer. However, a colposcopy examination can more readily detect these changes. During a colposcopic exam the practitioner can place a solution on the cervix that causes areas infected with HPV to become lighter than surrounding areas. This may indicate that colposcopy and biopsy should be incorporated into a standard of care for HIV-infected women.
Vigilant monitoring is required.
As many as 100 percent of positive women will have a recurrence of their cancer with in two months following definitive treatment. The statitsic that survival after recurrence averages nine months appeared to stun medical professionals in the audience at the presentation. Sex and drugs Many HIV-positive women express concern about the lack of hard data on the safety and efficacy of antiretroviral drugs in women. Weight and hormonal differences between men and women is usually the point of focus. Zerit, Videx and several other drugs are dosed based on body weight or volume.